Funding Opportunity: RFA for AMP PDRD

vdardov
Wed, 22 Oct 2025 17:35:11 +0000
Ideas and Inspiration

The FNIH has issued a request for applications (RFA) for the Accelerating Medicines Partnership® in Parkinson’s Disease and Related Disorders (AMP® PDRD). If you are a clinical investigator with established study cohorts in Parkinson’s disease, other alpha-synucleinopathies (including Lewy body dementia, multiple system atrophy, or REM sleep behavior disorder), or atypical parkinsonian syndromes, such as progressive supranuclear palsy, AMP PDRD invites you to apply. Investigators have the opportunity to perform biomarker analyses, fully funded by the AMP PDRD consortium, at no cost to the investigator.

_______

Request for Applications (RFA) intended for clinical research studies with wellcharacterized Parkinson’s disease, α-synucleinopathy, and atypical parkinsonism populations suitable for C2N PrecivityAD2™ and/or eMTBR-tau243 analyses

1 post - 1 participant

Read full topic